Effect of mesenchymal stem cells and fibroblast cells on chronic wound healing
Phase 2
- Conditions
- Chronic wound.Chronic ulcer of skin, not elsewhere classified
- Registration Number
- IRCT20090128001605N17
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Patients with chronic wound less than 1% of body surface due to vascular (arterial, venous and lymphatic), diabetic, radiotherapy, bed sore and ...
Exclusion Criteria
Pregnant Women
Any patients that is treated with medications that makes wound healing problematic, malignancy, or osteomyelitis in the wound
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Wound surface. Timepoint: every 3 days until 9 days after intervention. Method of measurement: Metric Software.
- Secondary Outcome Measures
Name Time Method